Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

AMERICAN JOURNAL OF KIDNEY DISEASES

Saved in:
Bibliographic Details
Main Authors: Lionel Rostaing, Suphamai Bunnapradist, Josep M. Grinyo, Kazimierz Ciechanowski, Jason E. Denny, Helio Tedesco Silva Jr, Klemens Budde, on behalf of the Envarsus Study Group
Other Authors: MEDICINE
Format: Article
Published: Elsevier 2022
Online Access:https://scholarbank.nus.edu.sg/handle/10635/229797
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-229797
record_format dspace
spelling sg-nus-scholar.10635-2297972024-04-17T08:37:18Z Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial Lionel Rostaing Suphamai Bunnapradist Josep M. Grinyo Kazimierz Ciechanowski Jason E. Denny Helio Tedesco Silva Jr Klemens Budde on behalf of the Envarsus Study Group MEDICINE AMERICAN JOURNAL OF KIDNEY DISEASES 67 4 648-659 2022-08-02T06:59:32Z 2022-08-02T06:59:32Z 2015-12-22 2022-07-24T08:01:56Z Article Lionel Rostaing, Suphamai Bunnapradist, Josep M. Grinyo, Kazimierz Ciechanowski, Jason E. Denny, Helio Tedesco Silva Jr, Klemens Budde, on behalf of the Envarsus Study Group (2015-12-22). Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial. AMERICAN JOURNAL OF KIDNEY DISEASES 67 (4) : 648-659. ScholarBank@NUS Repository. 02726386 https://scholarbank.nus.edu.sg/handle/10635/229797 Elsevier Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description AMERICAN JOURNAL OF KIDNEY DISEASES
author2 MEDICINE
author_facet MEDICINE
Lionel Rostaing
Suphamai Bunnapradist
Josep M. Grinyo
Kazimierz Ciechanowski
Jason E. Denny
Helio Tedesco Silva Jr
Klemens Budde
on behalf of the Envarsus Study Group
format Article
author Lionel Rostaing
Suphamai Bunnapradist
Josep M. Grinyo
Kazimierz Ciechanowski
Jason E. Denny
Helio Tedesco Silva Jr
Klemens Budde
on behalf of the Envarsus Study Group
spellingShingle Lionel Rostaing
Suphamai Bunnapradist
Josep M. Grinyo
Kazimierz Ciechanowski
Jason E. Denny
Helio Tedesco Silva Jr
Klemens Budde
on behalf of the Envarsus Study Group
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
author_sort Lionel Rostaing
title Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
title_short Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
title_full Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
title_fullStr Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
title_full_unstemmed Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
title_sort novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial
publisher Elsevier
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/229797
_version_ 1800915548964388864